A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

NCT02116582 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG: Enzalutamide

Sponsor

Astellas Pharma Europe B.V.

Collaborators

[object Object]